HK1027596A1 - Stereoselective microbial reduction of a racemic tetralone - Google Patents

Stereoselective microbial reduction of a racemic tetralone

Info

Publication number
HK1027596A1
HK1027596A1 HK00106703A HK00106703A HK1027596A1 HK 1027596 A1 HK1027596 A1 HK 1027596A1 HK 00106703 A HK00106703 A HK 00106703A HK 00106703 A HK00106703 A HK 00106703A HK 1027596 A1 HK1027596 A1 HK 1027596A1
Authority
HK
Hong Kong
Prior art keywords
microbial reduction
racemic tetralone
stereoselective microbial
stereoselective
tetralone
Prior art date
Application number
HK00106703A
Other languages
English (en)
Inventor
Brook Knight Morse
Susan Jane Truesdell
John Wing Wong
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HK1027596A1 publication Critical patent/HK1027596A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/24Preparation of oxygen-containing organic compounds containing a carbonyl group
    • C12P7/26Ketones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/002Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by oxidation/reduction reactions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK00106703A 1998-10-29 2000-10-23 Stereoselective microbial reduction of a racemic tetralone HK1027596A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10623398P 1998-10-29 1998-10-29

Publications (1)

Publication Number Publication Date
HK1027596A1 true HK1027596A1 (en) 2001-01-19

Family

ID=22310267

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00106703A HK1027596A1 (en) 1998-10-29 2000-10-23 Stereoselective microbial reduction of a racemic tetralone

Country Status (27)

Country Link
US (1) US6589777B1 (de)
EP (1) EP0997535B1 (de)
JP (2) JP3106135B2 (de)
KR (2) KR100432309B1 (de)
CN (1) CN1252277C (de)
AR (1) AR018967A1 (de)
AT (1) ATE328107T1 (de)
AU (1) AU751282B2 (de)
BR (1) BR9904964A (de)
CA (1) CA2287560C (de)
CY (1) CY1105148T1 (de)
CZ (1) CZ293579B6 (de)
DE (1) DE69931574T2 (de)
DK (1) DK0997535T3 (de)
ES (1) ES2264244T3 (de)
HK (1) HK1027596A1 (de)
HU (1) HUP9903941A3 (de)
ID (1) ID23591A (de)
IL (1) IL132500A0 (de)
IN (1) IN191494B (de)
PL (1) PL336331A1 (de)
PT (1) PT997535E (de)
RS (1) RS49702B (de)
RU (1) RU2235784C2 (de)
TR (1) TR199902668A2 (de)
TW (1) TWI224141B (de)
ZA (1) ZA996786B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN187170B (de) * 2000-01-04 2002-02-23 Sun Pharmaceutical Ind Ltd
US20050153408A1 (en) * 2001-11-28 2005-07-14 Tatsuya Honda Process for preparation of 2-aminotetralin derivatives and intermediates thereof
WO2015071861A2 (en) * 2013-11-14 2015-05-21 Biocon Limited Fungus mediated stereo-selective bioreduction of keto intermediates of pharmaceutically active compounds to their corresponding hydroxy compounds
CN104293856A (zh) * 2014-10-30 2015-01-21 青岛科技大学 一种细胞催化生产氟吡啶乙酮的方法
CN107418981B (zh) * 2017-06-27 2020-04-07 中山大学 白地霉菌株不对称催化还原卤代芳香酮的方法
CN107746861B (zh) * 2017-11-20 2020-06-23 浙江工业大学 一种(r)-1-(2-三氟甲基苯基)乙醇的生物制备方法
KR102319188B1 (ko) * 2019-06-04 2021-10-29 (주)이엔씨파워 횡단보도용 양면 표지판

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4857468A (en) * 1985-04-13 1989-08-15 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Process for preparing optically active 2-halo-1-phenyl ethanol
US5049497A (en) 1986-08-25 1991-09-17 Syntex (U.S.A.) Inc. Novel process for the synthesis of the enantiomers of bicyclo(4.2.0)oct-2-en-7-one and derivatives
US4839104A (en) 1987-06-11 1989-06-13 Pfizer, Inc. Process for preparing sertraline intermediates
US4777288A (en) 1987-06-11 1988-10-11 Pfizer Inc. Process for preparing a 4,4-diphenylbutanoic acid derivative
US4855500A (en) 1988-05-04 1989-08-08 Pfizer Inc. Process for preparing a ketimine
US4940731A (en) 1989-08-30 1990-07-10 Pfizer Inc. Method of treating premature ejaculation using sertraline
US5130338A (en) 1989-08-30 1992-07-14 Pfizer Inc. Method of treating chemical dependencies using sertraline
US4962128A (en) 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
US5082970A (en) 1991-03-06 1992-01-21 Pfizer Inc. Process for recycling amine isomer
GB9114947D0 (en) 1991-07-11 1991-08-28 Pfizer Ltd Process for preparing sertraline
GB9114948D0 (en) 1991-07-11 1991-08-28 Pfizer Ltd Process for preparing sertraline intermediates
US5196607A (en) 1992-02-14 1993-03-23 Pfizer Inc. Process for preparing ketone enantiomer
CA2117482C (en) 1992-03-13 2005-02-15 Maria-Regina Kula New ketonic ester reductases, its preparation and use for enzymatic redox reactions
US5248699A (en) 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
ES2093980T3 (es) 1992-08-28 1997-01-01 Zeneca Ltd Proceso de reduccion asimetrica, enzimatica, para producir derivados de 4h-tieno(2,3-6)tiopirano.
US5466880A (en) 1992-09-15 1995-11-14 Pfizer Inc. Process for preparing ketone enantiomer
CA2176500C (en) * 1993-11-30 1999-09-28 George J. Quallich Process for preparing a chiral tetralone
US5597826A (en) 1994-09-14 1997-01-28 Pfizer Inc. Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
US5618707A (en) 1996-01-04 1997-04-08 Schering Corporation Stereoselective microbial reduction of 5-fluorophenyl-5-oxo-pentanoic acid and a phenyloxazolidinone condensation product thereof

Also Published As

Publication number Publication date
HUP9903941A3 (en) 2001-04-28
EP0997535A3 (de) 2000-10-18
RS49702B (sr) 2007-12-31
TWI224141B (en) 2004-11-21
JP3106135B2 (ja) 2000-11-06
KR20030071731A (ko) 2003-09-06
PL336331A1 (en) 2000-05-08
JP3359905B2 (ja) 2002-12-24
PT997535E (pt) 2006-10-31
AU751282B2 (en) 2002-08-08
JP2000135098A (ja) 2000-05-16
BR9904964A (pt) 2000-12-12
CA2287560C (en) 2003-08-19
KR100432306B1 (ko) 2004-05-20
ZA996786B (en) 2001-04-30
KR100432309B1 (ko) 2004-05-20
JP2001054397A (ja) 2001-02-27
EP0997535B1 (de) 2006-05-31
HUP9903941A2 (hu) 2000-12-28
DE69931574T2 (de) 2006-11-02
IL132500A0 (en) 2001-03-19
ATE328107T1 (de) 2006-06-15
CY1105148T1 (el) 2010-03-03
DK0997535T3 (da) 2006-10-02
YU55199A (sh) 2003-04-30
ID23591A (id) 2000-05-04
AU5709799A (en) 2000-05-04
ES2264244T3 (es) 2006-12-16
CZ379099A3 (cs) 2000-05-17
DE69931574D1 (de) 2006-07-06
US6589777B1 (en) 2003-07-08
CA2287560A1 (en) 2000-04-29
HU9903941D0 (en) 1999-12-28
CN1255551A (zh) 2000-06-07
IN191494B (de) 2003-12-06
CN1252277C (zh) 2006-04-19
TR199902668A2 (xx) 2000-05-22
RU2235784C2 (ru) 2004-09-10
EP0997535A2 (de) 2000-05-03
CZ293579B6 (cs) 2004-06-16
KR20000029385A (ko) 2000-05-25
AR018967A1 (es) 2001-12-12

Similar Documents

Publication Publication Date Title
HK1027596A1 (en) Stereoselective microbial reduction of a racemic tetralone
AU3496699A (en) Bio-catalytic oxidation reactor
AU2964500A (en) Method of micro-fabrication
AU2919900A (en) A method of managing prepaid subscription information
AUPP670698A0 (en) A method of regulation
HUP0202836A3 (en) New use of a pyridazinone derivative
AU6386498A (en) A method of transformation
AUPO882497A0 (en) A method of genotyping
AU3741997A (en) A novel human mrna editing enzyme
AU4553999A (en) Arthropodicidal carboxanilides
AU2629599A (en) Purification of tramadol
AU1292500A (en) A divot retainer
AU1758695A (en) 2-(aminoalkoxy)phenylalkylamines with antiinflammatory activity
GB9826775D0 (en) Bacterial transcription regulators
AU5613600A (en) Enantiomers of n-desmethyl venlafaxine
AU3284399A (en) A method of labelling a sound or a representation thereof
GB9821136D0 (en) A set of parts
HK1068373A1 (en) Microbial biotransformation
AUPP486498A0 (en) A method of transformation
AU4436599A (en) Cd7
AU1141200A (en) A method of regulation
AUPQ337299A0 (en) A method of screening - ii
AUPP506298A0 (en) A method of diagnosis - II
AUPP515998A0 (en) A method of screening - II
AUPP644498A0 (en) A method of screening - ii

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091028